Drug Type mRNA |
Synonyms- |
Target |
Action inhibitors |
Mechanism PAH inhibitors(Phenylalanine hydroxylase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Phenylketonurias | Preclinical | China | 01 Jul 2025 | |
| Hereditary Angioedema | Preclinical | China | 19 Apr 2023 |





